<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37228606</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients.</ArticleTitle><Pagination><StartPage>1144224</StartPage><MedlinePgn>1144224</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1144224</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1144224</ELocationID><Abstract><AbstractText Label="BACKGROUND">Deep metabolomic, proteomic and immunologic phenotyping of patients suffering from an infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have matched a wide diversity of clinical symptoms with potential biomarkers for coronavirus disease 2019 (COVID-19). Several studies have described the role of small as well as complex molecules such as metabolites, cytokines, chemokines and lipoproteins during infection and in recovered patients. In fact, after an acute SARS-CoV-2 viral infection almost 10-20% of patients experience persistent symptoms post 12 weeks of recovery defined as long-term COVID-19 syndrome (LTCS) or long post-acute COVID-19 syndrome (PACS). Emerging evidence revealed that a dysregulated immune system and persisting inflammation could be one of the key drivers of LTCS. However, how these biomolecules altogether govern pathophysiology is largely underexplored. Thus, a clear understanding of how these parameters within an integrated fashion could predict the disease course would help to stratify LTCS patients from acute COVID-19 or recovered patients. This could even allow to elucidation of a potential mechanistic role of these biomolecules during the disease course.</AbstractText><AbstractText Label="METHODS">This study comprised subjects with acute COVID-19 (n=7; longitudinal), LTCS (n=33), Recov (n=12), and no history of positive testing (n=73). <sup>1</sup>H-NMR-based metabolomics with IVDr standard operating procedures verified and phenotyped all blood samples by quantifying 38 metabolites and 112 lipoprotein properties. Univariate and multivariate statistics identified NMR-based and cytokine changes.</AbstractText><AbstractText Label="RESULTS">Here, we report on an integrated analysis of serum/plasma by NMR spectroscopy and flow cytometry-based cytokines/chemokines quantification in LTCS patients. We identified that in LTCS patients lactate and pyruvate were significantly different from either healthy controls (HC) or acute COVID-19 patients. Subsequently, correlation analysis in LTCS group only among cytokines and amino acids revealed that histidine and glutamine were uniquely attributed mainly with pro-inflammatory cytokines. Of note, triglycerides and several lipoproteins (apolipoproteins Apo-A1 and A2) in LTCS patients demonstrate COVID-19-like alterations compared with HC. Interestingly, LTCS and acute COVID-19 samples were distinguished mostly by their phenylalanine, 3-hydroxybutyrate (3-HB) and glucose concentrations, illustrating an imbalanced energy metabolism. Most of the cytokines and chemokines were present at low levels in LTCS patients compared with HC except for IL-18 chemokine, which tended to be higher in LTCS patients.</AbstractText><AbstractText Label="CONCLUSION">The identification of these persisting plasma metabolites, lipoprotein and inflammation alterations will help to better stratify LTCS patients from other diseases and could help to predict ongoing severity of LTCS patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Berezhnoy, Bissinger, Liu, Cannet, Sch&#xe4;fer, Kienzle, Bitzer, H&#xe4;berle, G&#xf6;pel, Trautwein and Singh.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berezhnoy</LastName><ForeName>Georgy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bissinger</LastName><ForeName>Rosi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine I, University Hospital T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Institute of Women's Health, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cannet</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bruker BioSpin, Applied Industrial and Clinical Division, Ettlingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;fer</LastName><ForeName>Hartmut</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bruker BioSpin, Applied Industrial and Clinical Division, Ettlingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kienzle</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bitzer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Personalized Medicine, University Hospital T&#xfc;bingen, Tubingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe4;berle</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;pel</LastName><ForeName>Siri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trautwein</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Yogesh</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Research Institute of Women's Health, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Genetics and Applied Genomics, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Next Generation Sequencing (NGS) Competence Center T&#xfc;bingen (NCCT), University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018925">Chemokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001053">Apolipoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008074">Lipoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001053" MajorTopicYN="N">Apolipoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008074" MajorTopicYN="N">Lipoproteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NMR</Keyword><Keyword MajorTopicYN="N">Post-Acute COVID-19 syndrome (PACS)</Keyword><Keyword MajorTopicYN="N">in-vitro diagnostics</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">lipoproteins</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">quantitative</Keyword></KeywordList><CoiStatement>CC and HS are employed by Bruker BioSpin GmbH but were not involved in study design and analysis of the present data. Their contribution consisted in providing age- and sex-matched healthy control data and IVDr software. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>14</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37228606</ArticleId><ArticleId IdType="pmc">PMC10203989</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1144224</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO Live Dashboard . (2020). Available at: https://covid19.who.int.</Citation></Reference><Reference><Citation>Ceballos FC, Virseda-Berdices A, Resino S, Ryan P, Martinez-Gonzalez O, Perez-Garcia F, et al. . Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation. Front Immunol (2022) 13:925558. doi: 10.3389/fimmu.2022.925558</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.925558</ArticleId><ArticleId IdType="pmc">PMC9280146</ArticleId><ArticleId IdType="pubmed">35844615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JW, Su Y, Baloni P, Chen D, Pavlovitch-Bedzyk AJ, Yuan D, et al. . Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat Biotechnol (2022) 40:110&#x2013;20. doi: 10.1038/s41587-021-01020-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01020-4</ArticleId><ArticleId IdType="pmc">PMC9206886</ArticleId><ArticleId IdType="pubmed">34489601</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y, Trautwein C, Fendel R, Krickeberg N, Berezhnoy G, Bissinger R, et al. . SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells. Heliyon (2021) 7:e07147. doi: 10.1016/j.heliyon.2021.e07147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e07147</ArticleId><ArticleId IdType="pmc">PMC8159709</ArticleId><ArticleId IdType="pubmed">34075347</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhao J, Wang H, Wang W, Su X, Liao X, et al. . Metabolic defects of peripheral T cells in COVID-19 patients. J Immunol (2021) 206:2900&#x2013;8. doi: 10.4049/jimmunol.2100068</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100068</ArticleId><ArticleId IdType="pubmed">34049969</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Carroll SM, O&#x2019;Neill LAJ. Targeting immunometabolism to treat COVID-19. Immunother Adv (2021) 1:ltab013. doi: 10.1093/immadv/ltab013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/immadv/ltab013</ArticleId><ArticleId IdType="pmc">PMC8195165</ArticleId><ArticleId IdType="pubmed">34240083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornillet M, Strunz B, Rooyackers O, Ponzetta A, Chen P, Muvva JR, et al. . COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations. Eur J Immunol (2022) 52:503&#x2013;10. doi: 10.1002/eji.202149626</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202149626</ArticleId><ArticleId IdType="pmc">PMC9015354</ArticleId><ArticleId IdType="pubmed">34837225</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H, Liu C, Li D, Huang Q, Liu D, Zhang Y, et al. . Metabolomic analyses reveal new stage-specific features of COVID-19. Eur Respir J (2022) 59(2):2100284. doi: 10.1183/13993003.00284-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00284-2021</ArticleId><ArticleId IdType="pmc">PMC8311281</ArticleId><ArticleId IdType="pubmed">34289974</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M, Caterino M, Fedele R, Cevenini A, Pontillo M, Barra L, et al. . COVIDomics: the proteomic and metabolomic signatures of COVID-19. Int J Mol Sci (2022) 23(5):2414. doi: 10.3390/ijms23052414</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052414</ArticleId><ArticleId IdType="pmc">PMC8910221</ArticleId><ArticleId IdType="pubmed">35269564</ArticleId></ArticleIdList></Reference><Reference><Citation>Danlos FX, Grajeda-Iglesias C, Durand S, Sauvat A, Roumier M, Cantin D, et al. . Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis (2021) 12:258. doi: 10.1038/s41419-021-03540-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03540-y</ArticleId><ArticleId IdType="pmc">PMC7948172</ArticleId><ArticleId IdType="pubmed">33707411</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Shu T, Yang X, Song J-X, Zhang M, Yao C, et al. . Plasma metabolomic and lipidomic alterations associated with COVID-19. Natl Sci Rev (2020) 7(7):1157&#x2013;68. doi: 10.1093/nsr/nwaa086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa086</ArticleId><ArticleId IdType="pmc">PMC7197563</ArticleId><ArticleId IdType="pubmed">34676128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge S, Nitschke P, Kimhofer T, Coudert JD, Begum S, Bong SH, et al. . NMR spectroscopic windows on the systemic effects of SARS-CoV-2 infection on plasma lipoproteins and metabolites in relation to circulating cytokines. J Proteome Res (2021) 20:1382&#x2013;96. doi: 10.1021/acs.jproteome.0c00876</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00876</ArticleId><ArticleId IdType="pubmed">33426894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Q, Chen M, Zhang Z, Yuan Y, Wang H, Hao Y, et al. . Machine learning of serum metabolic patterns encodes asymptomatic SARS-CoV-2 infection. Front Chem (2021) 9:746134. doi: 10.3389/fchem.2021.746134</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2021.746134</ArticleId><ArticleId IdType="pmc">PMC8517325</ArticleId><ArticleId IdType="pubmed">34660538</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan MA, Al-Sakkaf K, Shait Mohammed MR, Dallol A, Al-Maghrabi J, Aldahlawi A, et al. . Integration of transcriptome and metabolome provides unique insights to pathways associated with obese breast cancer patients. Front Oncol (2020) 10:804. doi: 10.3389/fonc.2020.00804</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.00804</ArticleId><ArticleId IdType="pmc">PMC7248369</ArticleId><ArticleId IdType="pubmed">32509585</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, et al. . Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell (2020) 183:1479&#x2013;1495 e20. doi: 10.1016/j.cell.2020.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Zhang T, Xue K, Fang Z, Jiang G, Huang S, et al. . Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients. Anal Chim Acta (2021) 1180:338881. doi: 10.1016/j.aca.2021.338881</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338881</ArticleId><ArticleId IdType="pmc">PMC8310733</ArticleId><ArticleId IdType="pubmed">34538334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L, Jiang H, Chen Y, Gu S, Xia J, Zhang H, et al. . The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal Chim Acta (2021) 1152:338267. doi: 10.1016/j.aca.2021.338267</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338267</ArticleId><ArticleId IdType="pmc">PMC7847702</ArticleId><ArticleId IdType="pubmed">33648648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Li X, Ning W, Gong S, Yang F, Fang C, et al. . Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19. Theranostics (2021) 11:8008&#x2013;26. doi: 10.7150/thno.61832</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.61832</ArticleId><ArticleId IdType="pmc">PMC8315065</ArticleId><ArticleId IdType="pubmed">34335977</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Chen D, Ding W, Wu P, Hou H, Bai Y, et al. . The trans-omics landscape of COVID-19. Nat Commun (2021) 12:4543. doi: 10.1038/s41467-021-24482-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24482-1</ArticleId><ArticleId IdType="pmc">PMC8316550</ArticleId><ArticleId IdType="pubmed">34315889</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Bao L, Deng W, Liu J, Ren E, Lv Q, et al. . Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Signal Transduct Target Ther (2022) 7:29. doi: 10.1038/s41392-022-00891-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00891-6</ArticleId><ArticleId IdType="pmc">PMC8795751</ArticleId><ArticleId IdType="pubmed">35091528</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YM, Zheng Y, Yu Y, Wang Y, Huang Q, Qian F, et al. . Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J (2020) 39:e105896. doi: 10.15252/embj.2020105896</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105896</ArticleId><ArticleId IdType="pmc">PMC7737620</ArticleId><ArticleId IdType="pubmed">33140861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizkarguenaga M, Bruzzone C, Gil-Redondo R, SanJuan I, Martin-Ruiz I, Barriales D, et al. . Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR BioMed (2022) 35:e4637. doi: 10.1002/nbm.4637</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.4637</ArticleId><ArticleId IdType="pmc">PMC8646702</ArticleId><ArticleId IdType="pubmed">34708437</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Jones S, Vangeti S, Yu M, Falck-Jones R, Cagigi A, Badolati I, et al. . Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. J Clin Invest (2021) 131(6):e144734. doi: 10.1172/JCI144734</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI144734</ArticleId><ArticleId IdType="pmc">PMC7954608</ArticleId><ArticleId IdType="pubmed">33492309</ArticleId></ArticleIdList></Reference><Reference><Citation>Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, et al. . An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight (2021) 6(1):e144455. doi: 10.1172/jci.insight.144455</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.144455</ArticleId><ArticleId IdType="pmc">PMC7821609</ArticleId><ArticleId IdType="pubmed">33232303</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI, et al. . Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites (2022) 12(11):1026. doi: 10.3390/metabo12111026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa HL, Deus LA, Araujo TB, Reis AL, Amorim CEN, Gadelha AB, et al. . Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: a Brazilian study. Front Immunol (2022) 13:1006076. doi: 10.3389/fimmu.2022.1006076</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1006076</ArticleId><ArticleId IdType="pmc">PMC9562993</ArticleId><ArticleId IdType="pubmed">36248863</ArticleId></ArticleIdList></Reference><Reference><Citation>Letertre MPM, Giraudeau P, de Tullio P. Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: current challenges and perspectives. Front Mol Biosci (2021) 8:698337. doi: 10.3389/fmolb.2021.698337</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.698337</ArticleId><ArticleId IdType="pmc">PMC8488110</ArticleId><ArticleId IdType="pubmed">34616770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimhofer T, Lodge S, Whiley L, Gray N, Loo RL, Lawler NG, et al. . Integrative modeling of quantitative plasma lipoprotein, metabolic, and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2 infection. J Proteome Res (2020) 19:4442&#x2013;54. doi: 10.1021/acs.jproteome.0c00519</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00519</ArticleId><ArticleId IdType="pubmed">32806897</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia BSB, Ferreira VG, Piagge PMFD, Almeida MB, Assun&#xe7;&#xe3;o NA, Raimundo JRS, et al. . 1H qNMR-based metabolomics discrimination of covid-19 severity. J Proteome Res (2022) 21:1640&#x2013;53. doi: 10.1021/acs.jproteome.1c00977</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00977</ArticleId><ArticleId IdType="pubmed">35674498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V, Maggi L, Mazzoni A, Spinicci M, Zammarchi L, Bartoloni A, et al. . Serum NMR profiling reveals differential alterations in the lipoproteome induced by pfizer-BioNTech vaccine in COVID-19 recovered subjects and na&#xef;ve subjects. Front Mol Biosci (2022) 9:839809. doi: 10.3389/fmolb.2022.839809</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.839809</ArticleId><ArticleId IdType="pmc">PMC9037139</ArticleId><ArticleId IdType="pubmed">35480886</ArticleId></ArticleIdList></Reference><Reference><Citation>Meoni G, Ghini V, Maggi L, Vignoli A, Mazzoni A, Salvati L, et al. . Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab. PloS Pathog (2021) 17:e1009243. doi: 10.1371/journal.ppat.1009243</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009243</ArticleId><ArticleId IdType="pmc">PMC7877736</ArticleId><ArticleId IdType="pubmed">33524041</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. . Incomplete systemic recovery and metabolic phenoreversion in post-Acute-Phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res (2021) 20:3315&#x2013;29. doi: 10.1021/acs.jproteome.1c00224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda R, Lodge S, Nitschke P, Spraul M, Schaefer H, Bong SH, et al. . Integrative modeling of plasma metabolic and lipoprotein biomarkers of SARS-CoV-2 infection in Spanish and Australian COVID-19 patient cohorts. J Proteome Res (2021) 20:4139&#x2013;52. doi: 10.1021/acs.jproteome.1c00458</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00458</ArticleId><ArticleId IdType="pubmed">34251833</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitschke P, Lodge S, Hall D, Schaefer H, Spraul M, Embade N, et al. . Direct low field J-edited diffusional proton NMR spectroscopic measurement of COVID-19 inflammatory biomarkers in human serum. Analyst (2022) 147:4213&#x2013;21. doi: 10.1039/D2AN01097F</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2AN01097F</ArticleId><ArticleId IdType="pubmed">35994017</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmelter F, F&#xf6;h B, Mallagaray A, Rahm&#xf6;ller J, Ehlers M, Lehrian S, et al. . Metabolic and lipidomic markers differentiate COVID-19 from non-hospitalized and other intensive care patients. Front Mol Biosci (2021) 8:737039. doi: 10.3389/fmolb.2021.737039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.737039</ArticleId><ArticleId IdType="pmc">PMC8686182</ArticleId><ArticleId IdType="pubmed">34938772</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossler T, Berezhnoy G, Singh Y, Cannet C, Reinsperger T, Schafer H, et al. . Quantitative serum NMR spectroscopy stratifies COVID-19 patients and sheds light on interfaces of host metabolism and the immune response with cytokines and clinical parameters. Metabolites (2022) 12(12):1277. doi: 10.3390/metabo12121277</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12121277</ArticleId><ArticleId IdType="pmc">PMC9781847</ArticleId><ArticleId IdType="pubmed">36557315</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, et al. . MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res (2021) 49:W388&#x2013;96. doi: 10.1093/nar/gkab382</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab382</ArticleId><ArticleId IdType="pmc">PMC8265181</ArticleId><ArticleId IdType="pubmed">34019663</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacklies W, Redestig H, Scholz M, Walther D, Selbig J. pcaMethods&#x2013;a bioconductor package providing PCA methods for incomplete data. Bioinformatics (2007) 23:1164&#x2013;7. doi: 10.1093/bioinformatics/btm069</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm069</ArticleId><ArticleId IdType="pubmed">17344241</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Appl 1H NMR metabonom Anal Chem (2006) 78:4281&#x2013;90. doi: 10.1021/ac051632c</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac051632c</ArticleId><ArticleId IdType="pubmed">16808434</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z, Zhou G, Chong J, Xia J. Comprehensive meta-analysis of COVID-19 global metabolomics datasets. Metabolites (2021) 11(1):44. doi: 10.3390/metabo11010044</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11010044</ArticleId><ArticleId IdType="pmc">PMC7827862</ArticleId><ArticleId IdType="pubmed">33435351</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med (2021) 9(2):129. doi: 10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Karu N, Kindt A, van Gammeren AJ, Ermens AAM, Harms AC, Portengen L, et al. . Severe COVID-19 is characterised by perturbations in plasma amines correlated with immune response markers, and linked to inflammation and oxidative stress. Metabolites (2022) 12(7):618. doi: 10.3390/metabo12070618</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070618</ArticleId><ArticleId IdType="pmc">PMC9321395</ArticleId><ArticleId IdType="pubmed">35888742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Ji X, Rahman I. SARS-CoV2 infection alters tryptophan catabolism and phospholipid metabolism. Metabolites (2021) 11(10):659. doi: 10.3390/metabo11100659</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11100659</ArticleId><ArticleId IdType="pmc">PMC8538244</ArticleId><ArticleId IdType="pubmed">34677374</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan S, Nordqvist H, Ambikan AT, Gupta S, Sperk M, Svensson-Akusjarvi S, et al. . Metabolic perturbation associated with COVID-19 disease severity and SARS-CoV-2 replication. Mol Cell Proteomics (2021) 20:100159. doi: 10.1016/j.mcpro.2021.100159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2021.100159</ArticleId><ArticleId IdType="pmc">PMC8490130</ArticleId><ArticleId IdType="pubmed">34619366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis HM, Liu Y, Frampas CF, Longman K, Spick M, Stewart A, et al. . Metabolomics markers of COVID-19 are dependent on collection wave. Metabolites (2022) 12(8):713. doi: 10.3390/metabo12080713</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12080713</ArticleId><ArticleId IdType="pmc">PMC9415837</ArticleId><ArticleId IdType="pubmed">36005585</ArticleId></ArticleIdList></Reference><Reference><Citation>Dona AC, Jim&#xe9;nez B, Sch&#xe4;fer H, Humpfer E, Spraul M, Lewis MR, et al. . Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for Large-scale metabolic phenotyping. Anal Chem (2014) 86:9887&#x2013;94. doi: 10.1021/ac5025039</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac5025039</ArticleId><ArticleId IdType="pubmed">25180432</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone C, Bizkarguenaga M, Gil-Redondo R, Diercks T, Arana E, Garcia de Vicuna A, et al. . SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience (2020) 23:101645. doi: 10.1016/j.isci.2020.101645</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101645</ArticleId><ArticleId IdType="pmc">PMC7534591</ArticleId><ArticleId IdType="pubmed">33043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gafson AR, Thorne T, McKechnie CIJ, Jimenez B, Nicholas R, Matthews PM. Lipoprotein markers associated with disability from multiple sclerosis. Sci Rep (2018) 8:17026. doi: 10.1038/s41598-018-35232-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35232-7</ArticleId><ArticleId IdType="pmc">PMC6242870</ArticleId><ArticleId IdType="pubmed">30451923</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindelar M, Stancliffe E, Schwaiger-Haber M, Anbukumar DS, Adkins-Travis K, Goss CW, et al. . Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med (2021) 2:100369. doi: 10.1016/j.xcrm.2021.100369</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100369</ArticleId><ArticleId IdType="pmc">PMC8292035</ArticleId><ArticleId IdType="pubmed">34308390</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyukozkan M, Alvarez-Mulett S, Racanelli AC, Schmidt F, Batra R, Hoffman KL, et al. . Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19. iScience (2022) 25:104612. doi: 10.1016/j.isci.2022.104612</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104612</ArticleId><ArticleId IdType="pmc">PMC9212983</ArticleId><ArticleId IdType="pubmed">35756895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V, Meoni G, Pelagatti L, Celli T, Veneziani F, Petrucci F, et al. . Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients. PloS Pathog (2022) 18:e1010443. doi: 10.1371/journal.ppat.1010443</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010443</ArticleId><ArticleId IdType="pmc">PMC9022834</ArticleId><ArticleId IdType="pubmed">35446921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, et al. . Multi-omics provide evidence for an anti-inflammatory immune signature and metabolic alterations in patients with Long COVID Syndrome &#x2013; an exploratory study. medRxiv, preprint (2022). doi: 10.1371/journal.ppat.1010443</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010443</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer PE, Kirwan JP, Rosen CJ. Post-acute sequelae of COVID-19: a metabolic perspective. Elife (2022) 11:e78200. doi: 10.7554/eLife.78200</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. . Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine (2020) 55:102763. doi: 10.1016/j.ebiom.2020.102763</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. . An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med (2020) 26(10):1636&#x2013;43. doi: 10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Irino Y, Toh R, Nagao M, Mori T, Honjo T, Shinohara M, et al. . 2-aminobutyric acid modulates glutathione homeostasis in the myocardium. Sci Rep (2016) 6:36749. doi: 10.1038/srep36749</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36749</ArticleId><ArticleId IdType="pmc">PMC5101505</ArticleId><ArticleId IdType="pubmed">27827456</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D, Yan R, Lv L, Jiang H, Lu Y, Sheng J, et al. . The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism (2021) 118:154739. doi: 10.1016/j.metabol.2021.154739</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154739</ArticleId><ArticleId IdType="pmc">PMC7920809</ArticleId><ArticleId IdType="pubmed">33662365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansone L, Briviba M, Silamikelis I, Terentjeva A, Perkons I, Birzniece L, et al. . Amino acid metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis. Microbiol Spectr (2021) 9:e00338&#x2013;21. doi: 10.1128/spectrum.00338-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00338-21</ArticleId><ArticleId IdType="pmc">PMC8653833</ArticleId><ArticleId IdType="pubmed">34878333</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Balena A, Masi D, Tozzi R, Risi R, Caputi A, et al. . Central obesity improvement and blood glucose reduction are associated with a stronger adaptive immune response following COVID-19 mRNA vaccine. Vaccines (Basel) (2022) 10:79. doi: 10.3390/vaccines10010079</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010079</ArticleId><ArticleId IdType="pmc">PMC8780354</ArticleId><ArticleId IdType="pubmed">35062740</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Chen J, Liang Q, Zheng H, Ye Y, Nan W, et al. . Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia. Respir Res (2022) 23:172. doi: 10.1186/s12931-022-02075-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02075-w</ArticleId><ArticleId IdType="pmc">PMC9235271</ArticleId><ArticleId IdType="pubmed">35761396</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic Encephalomyelitis/Chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clinic Proc (2021) 96:2861&#x2013;78. doi: 10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M, Horriatkhah E, Mohajery R. The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case&#x2013;control study. Inflammopharmacology (2021) 29:1769&#x2013;76. doi: 10.1007/s10787-021-00881-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00881-0</ArticleId><ArticleId IdType="pmc">PMC8552429</ArticleId><ArticleId IdType="pubmed">34709541</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranovicova E, Bobcakova A, Vysehradsky R, Dankova Z, Halasova E, Nosal V, et al. . The ability to normalise energy metabolism in advanced COVID-19 disease seems to be one of the key factors determining the disease progression&#x2013;a metabolomic NMR study on blood plasma. Appl Sci (2021) 11:4231. doi: 10.3390/app11094231</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app11094231</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbaum L, Ghataorhe P, Wharton J, Jim&#xe9;nez B, Howard LSG, Gibbs JSR, et al. . Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension. Thorax (2019) 74:380&#x2013;9. doi: 10.1136/thoraxjnl-2018-212144</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-212144</ArticleId><ArticleId IdType="pmc">PMC6475111</ArticleId><ArticleId IdType="pubmed">30478197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazenwadel J, Berezhnoy G, Cannet C, Sch&#xe4;fer H, Geisler T, Rohlfing A-K, et al. . Stratification of hypertensive COVID-19 patients by quantitative NMR spectroscopy of serum metabolites, lipoproteins, inflammation markers. medRxiv, preprint, (2022). doi: 10.1101/2022.12.20.22283729</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.20.22283729</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceperuelo-Mallafre V, Reverte L, Peraire J, Madeira A, Maymo-Masip E, Lopez-Dupla M, et al. . Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes. Front Immunol (2022) 13:912579. doi: 10.3389/fimmu.2022.912579</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.912579</ArticleId><ArticleId IdType="pmc">PMC9515795</ArticleId><ArticleId IdType="pubmed">36189213</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpen&#xe8; G, Onorato D, Nocini R, Fortunato G, Rizk JG, Henry BM, et al. . Blood lactate concentration in COVID-19: a systematic literature review. Clin Chem Lab Med (2022) 60:332&#x2013;7. doi: 10.1515/cclm-2021-1115</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1115</ArticleId><ArticleId IdType="pubmed">34856090</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, et al. . Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight (2020) 5(17):e140329. doi: 10.1172/jci.insight.140329</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140329</ArticleId><ArticleId IdType="pmc">PMC7526441</ArticleId><ArticleId IdType="pubmed">32687484</ArticleId></ArticleIdList></Reference><Reference><Citation>Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, et al. . Ultra-High-Throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst (2020) 11:11&#x2013;24 e4. doi: 10.1016/j.cels.2020.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7264033</ArticleId><ArticleId IdType="pubmed">32619549</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. . Proteomic and metabolomic characterization of COVID-19 patient sera. Cell (2020) 182:59&#x2013;72 e15. doi: 10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>